These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7063244)

  • 21. Estracyt--clinical experiences.
    Nilsson T
    Scand J Urol Nephrol Suppl; 1980; 55():135-8. PubMed ID: 6938016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU
    Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience with Estracyt.
    Nilsson T
    Acta Urol Belg; 1980 Jan; 48(1):133-7. PubMed ID: 7435349
    [No Abstract]   [Full Text] [Related]  

  • 24. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J; Jung JL; Bittard M
    J Urol (Paris); 1984; 90(1):27-33. PubMed ID: 6725973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Personal experience with treatment of advanced prostatic carcinoma using Estracyt].
    Morávek P
    Rozhl Chir; 1987 Nov; 66(11):749-52. PubMed ID: 3424018
    [No Abstract]   [Full Text] [Related]  

  • 26. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Estramustine phosphate in the treatment of stage D prostatic carcinoma].
    van Wyk J
    S Afr Med J; 1978 Oct; 54(16):638. PubMed ID: 741271
    [No Abstract]   [Full Text] [Related]  

  • 28. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T; Haukaas S
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    JAMA; 1977 Jun; 237(23):2471. PubMed ID: 576957
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of advanced prostatic carcinoma using estramustinphosphate].
    Ferrer Roda J
    Actas Urol Esp; 1983; 7(1):29-34. PubMed ID: 6192690
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M; Lutherer S; Terhorst B
    Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A current review of the clinical experience with Estracyt.
    Murphy GP
    Prog Clin Biol Res; 1987; 243B():221-5. PubMed ID: 3309982
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J; Catane R
    J Med; 1984; 15(1):35-43. PubMed ID: 6593404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estracyt--mode of action and clinical experience.
    Hedlund PO
    Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981
    [No Abstract]   [Full Text] [Related]  

  • 37. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
    Jönsson G; Högberg B; Nilsson T
    Scand J Urol Nephrol; 1977; 11(3):231-8. PubMed ID: 339329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A; Zattoni F; Frustaci S; Galligioni E; Tirelli U; Trovó G; Tumolo S; Merlo A; Artuso G; Cosciani-Cunico S; Grigoletto E
    Prostate; 1982; 3(2):159-64. PubMed ID: 7088731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.